AdvanCell, Inc. funding

AdvanCell, Inc., a biotechnology company based in Cambridge, MA (founded 2026), filed a Form D with the SEC on July 16, 2026 and reported $218M raised of a $315M offering.

Amount raised$218M

Offering size$315M

Filed with the SECJuly 16, 2026

First saleJune 30, 2026

IndustryBiotechnology

SecuritiesEquity, Security to be acquired on exercise

LocationCambridge, MA

Founded2026

Entity typeCorporation

Investors so far41

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 16

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care